D

Doxa AB
STO:DOXA

Watchlist Manager
Doxa AB
STO:DOXA
Watchlist
Price: 0.4295 SEK 2.26% Market Closed
Market Cap: kr552.1m

Doxa AB
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Doxa AB
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
D
Doxa AB
STO:DOXA
Other
kr5.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Other
-kr8.9m
CAGR 3-Years
-34%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Other
kr72.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Other
-€500k
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Doxa AB
Glance View

Market Cap
552.1m SEK
Industry
Health Care

Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.

DOXA Intrinsic Value
0.0639 SEK
Overvaluation 85%
Intrinsic Value
Price kr0.4295
D

See Also

What is Doxa AB's Other?
Other
5.6m SEK

Based on the financial report for Dec 31, 2025, Doxa AB's Other amounts to 5.6m SEK.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett